Pediatric Radiology

, Volume 26, Issue 6, pp 409–415

Perflubron as a gastrointestinal MR imaging contrast agent in the pediatric population

  • G. S. BissetIII
  • K. H. Emery
  • M. P. Meza
  • N. K. Rollins
  • S. Don
  • J. S. Shorr
Article

Abstract

Objective. To evaluate the safety and efficacy of orally administered perflubron for bowel recognition on MR imaging in a pediatric population.Materials and methods. A multicenter trial evaluated 39 pediatric subjects before and after ingestion of perflubron with T1−, proton-density, and T2-weighted sequences through the abdomen and/or pelvis. Post-contrast images were compared with pre-contrast images. Safety was evaluated through assessment of adverse events, clinical laboratory parameters, and vital signs.Results. With regard to efficacy analysis, improvement in the percent of bowel darkened was observed for 85 % of the subjects on T1-weighted images and for 95% of the subjects on proton-density and T2-weighted images. For images of the abdominal region, the percent of bowel darkened was improved for 90–92 % of the subjects across pulse sequences. Improvement rates for the images of the pelvic region ranged from 71 % to 100 %. For at least 75 % of the subjects, proton-density and T2-weighted images of the body and tail of the pancreas, left lobe of the liver, mesenteric fat, and pathological tissue were improved relative to predosing images. Twenty-three percent of the subjects experienced some adverse effects, most of which were minor and related to the digestive system. Clinical laboratory and vital sign evaluations revealed no trends associated with the administration of perflubron.Conclusion. Perflubron is a relatively safe and effective gastrointestinal MR contrast agent in the pediatric population.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bisset GS (1989) Evaluation of potential practical oral contrast agents for pediatric magnetic resonance imaging. Preliminary observations. Pediatr Radiol 20: 61–66PubMedGoogle Scholar
  2. 2.
    Brown JJ, Duncan JR, Heiken JP, et al (1991) Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 181: 455–460PubMedGoogle Scholar
  3. 3.
    Patten RM, Lo SK, Phillips JJ, et al (1993) Positive bowel contrast agent for MR imaging of the abdomen: phase-11 and -111 clinical trials. Radiology 189: 277–283PubMedGoogle Scholar
  4. 4.
    Tart RP, Li KC, Storm BL, Rolfes RJ, Ang PG (1991) Enteric MRI contrast agents: comparative study of five potential agents in humans. Magn Reson Imaging 9: 559–568PubMedGoogle Scholar
  5. 5.
    Laniado M, Kornmesser W, Hamm B, Clauss W, Weinmann HJ, Felix R (1988) MR imaging of the gastrointestinal tract: value of Gd-DTPA. AJR 150: 817–821PubMedGoogle Scholar
  6. 6.
    Mattrey RF, Hajek PC, Gylys-Morin VM, et al (1987) Perfluorochemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans. AJR 148:1259–1263PubMedGoogle Scholar
  7. 7.
    Bach Gansmo T, Dupas B, Gayet Delacroix M, Lambrechts M (1993) Abdominal MRI using a negative contrast agent. Br J Radiol 66: 420–425PubMedGoogle Scholar
  8. 8.
    Mattrey RF, Trambert MA, Brown JJ, et al (1994) Perflubron as an oral contrast agent for MR imaging: results of a phase-III clinical trial. Radiology 191: 841–848PubMedGoogle Scholar
  9. 9.
    Listinsky JJ, Bryant RG (1988) Gastrointestinal contrast agents: a diamagnetic approach. Magn Reson Med 8: 285–292PubMedGoogle Scholar
  10. 10.
    Van Beers B, Grandin C, Jamart J, Demeure R, Jacobsen TF, Pringot J (1992) Magnetic resonance imaging of lower abdominal and pelvic lesions: assessment of oral magnetic particles as an intestinal contrast agent. Eur J Radiol 14: 252–257PubMedGoogle Scholar
  11. 11.
    Rubin DL, Muller HH, Nino Murcia M, Sidhu M, Christy V, Young SW (1991) Intraluminal contrast enhancement and MR visualization of the bowel wall: efficacy of PFOB. JMRI 1: 371–380PubMedGoogle Scholar
  12. 12.
    Kaminsky S, Laniado M, Gogoll M, et al (1991) Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy. Radiology 178: 503–508PubMedGoogle Scholar
  13. 13.
    Hahn PF, Stark DD, Lewis JM, et al (1990) First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 175: 695–700PubMedGoogle Scholar
  14. 14.
    Lonnemark M, Hemmingsson J, Carlsten J, Ericsson A, Holtz E, Klaveness J (1988) Superparamagnetic particles as an MRI contrast agent for the gastrointestinal tract. Acta Radiol 19: 599–602Google Scholar
  15. 15.
    Li KC, Ang PG, Tart RP, Storm BL, Rolfes R, Ho Tai PC (1990) Paramagnetic oil emulsions as oral magnetic resonance imaging contrast agents. Magn Reson Imaging 8: 589–598PubMedGoogle Scholar
  16. 16.
    Nunnally R (1984) Improved MR imaging of the upper abdomen with glucagon and gas. J Comput Assist Tomogr 8:835–838PubMedGoogle Scholar
  17. 17.
    Pels Rijcken TH, Davis MA, Ros PR (1994) Intraluminal contrast agents for MR imaging of the abdomen and pelvis. J Magn Reson Imaging 4: 291–300PubMedGoogle Scholar
  18. 18.
    Li KCP, Tart RP, Fitzsimmons JR, Storm BL, Mao J, Rolfes RJ (1991) Barium sulfate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies. Magn Reson Imaging 9: 141–150PubMedGoogle Scholar
  19. 19.
    Marti Bonmati L, Vilar U, Paniagua JC, Talens A (1991) High-density barium sulphate as an MRI oral contrast. Magn Reson Imaging 9: 259–261PubMedGoogle Scholar
  20. 20.
    Hahn PF, Stark DD, Saini S, Lewis JM, Wittenberg J, Ferrucci JT (1987) Ferrite particles for bowel contrast in MR imaging: design issues and feasibility studies. Radiology 164:37–41PubMedGoogle Scholar
  21. 21.
    Schumacher DJ, Steinbach G, Keane S, Buxton RB, Unger E, Mattrey RF (1991) Comparison of artifacts generated by oral MRI contrast agents in vitro. Invest Radiol 26 [Suppl]: 1125Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • G. S. BissetIII
    • 1
  • K. H. Emery
    • 2
  • M. P. Meza
    • 3
  • N. K. Rollins
    • 4
  • S. Don
    • 5
  • J. S. Shorr
    • 6
  1. 1.Department of RadiologyDuke University Medical CenterDurhamUSA
  2. 2.University of Cincinnati College of Medicine and Children's HospitalMedical CenterCincinnatiUSA
  3. 3.Department of RadiologyChildren's Hospital of PittsburghPittsburghUSA
  4. 4.Radiology Department, Children's Medical CenterUniversity of Texas and Southwestern Medical SchoolDallasUSA
  5. 5.Department of RadiologyMallinckrodt Institute of RadiologySt. LouisUSA
  6. 6.Alliance Pharmaceutical CorporationSan DiegoUSA

Personalised recommendations